Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Mar 5:12:1513598.
doi: 10.3389/fmed.2025.1513598. eCollection 2025.

The hepatocellular model of fatty liver disease: from current imaging diagnostics to innovative proteomics technologies

Affiliations
Review

The hepatocellular model of fatty liver disease: from current imaging diagnostics to innovative proteomics technologies

Renee Hernandez et al. Front Med (Lausanne). .

Abstract

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a prevalent chronic liver condition characterized by lipid accumulation and inflammation, often progressing to severe liver damage. We aim to review the pathophysiology, diagnostics, and clinical care of MASLD, and review highlights of advances in proteomic technologies. Recent advances in proteomics technologies have improved the identification of novel biomarkers and therapeutic targets, offering insight into the molecular mechanisms underlying MASLD progression. We focus on the application of mass spectrometry-based proteomics including single cell proteomics, proteogenomics, extracellular vesicle (EV-omics), and exposomics for biomarker discovery, emphasizing the potential of blood-based panels for noninvasive diagnosis and personalized medicine. Future research directions are presented to develop targeted therapies and improve clinical outcomes for MASLD patients.

Keywords: MASH; MASLD; exposomics; proteogenomics; proteomics; single-cell.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Proteomic workflow is used for sample preparation, mass spectrometry analysis, and bioinformatics.
Figure 2
Figure 2
Extracellular vesicles from blood or adipose tissues of MASLD patients present the potential for biomarkers of MASLD.

Similar articles

Cited by

References

    1. Juanola O, Martínez-López S, Francés R, Gómez-Hurtado I. Non-alcoholic fatty liver disease: metabolic, genetic, epigenetic and environmental risk factors. Int J Environ Res Public Health. (2021) 18:227. doi: 10.3390/ijerph18105227, PMID: - DOI - PMC - PubMed
    1. Manusov EG, Diego VP, Smith J, Garza JR, Lowdermilk J, Blangero J, et al. . UniMóvil: a Mobile health clinic providing primary care to the Colonias of the Rio Grande Valley, South Texas. Front Public Health. (2019) 7:215. doi: 10.3389/fpubh.2019.00215, PMID: - DOI - PMC - PubMed
    1. Targher G, Corey KE, Byrne CD. NAFLD, and cardiovascular and cardiac diseases: factors influencing risk, prediction and treatment. Diabetes Metab. (2021) 47:101215. doi: 10.1016/j.diabet.2020.101215, PMID: - DOI - PubMed
    1. Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. . The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. (2018) 67:328–57. doi: 10.1002/hep.29367, PMID: - DOI - PubMed
    1. Bessone F, Razori MV, Roma MG. Molecular pathways of nonalcoholic fatty liver disease development and progression. Cell Mol Life Sci. (2019) 76:99–128. doi: 10.1007/s00018-018-2947-0, PMID: - DOI - PMC - PubMed

LinkOut - more resources